University Medical Center Utrecht
Infant Microbiome Development Traced to Multiple Maternal Transmission Sources
Researchers assessed maternal and infant samples over time, uncovering a similar proportion of maternal microbes in microbiomes from cesarean or vaginal birth babies.
Inherited Cancer Risk Detected in Significant Subset of Wilms Tumor Cases
Researchers detected hereditary cancer susceptibility in around one-third of the Wilms tumor cases profiled in the Netherlands.
Metastatic Tumor Profiles Lead to Potential Treatment Targets
Tumor genomes from almost 2,400 patients with metastatic cancer revealed a range of somatic alterations, providing a foundation for clinical sequencing efforts.
Netherlands Drug Repurposing, Tumor Profiling Trial Results Reported at ESMO
The early-stage genomics-based trials suggest tumor sequence can be informative for late-stage cancers, as an ESMO group seeks clinically meaningful translation.
Cyclomics, a 2018 spinout from University Medical Center Utrecht, is testing its assay for treatment response and recurrence monitoring in head and neck cancer.